Flunarizine Dihydrochloride BP

Composition: Migon Tablet: Each Film Coated tablet contains Flunarizine 1O mg as Flunarizine Dihydrochloride BP.

Indications: Flunarizine tablets are indicated for the treatment of prophylaxis of classic (with aura) or common (without aura) migraine, Symptomatic treatment of vestibular vertigo (due to a diagnosed functional disorder of the vestibular system), Peripheral vascular disease (PVD), Motion sickness, Refractory epilepsy resistant to conventoinal antiepilepitc therapy.

Dosage & Administration: Adults and elderly-Migraine prophylaxis: Starting Dose- 10 mg daily (at night) for adult patients aged 18 to 64 years and 5 mg daily (at night) for elderly patients aged 65 years and older. If during this treatment depressive, extra pyramidal & other unacceptable adverse experiences occur, administration should be discontinued. If after 2 months of this initial treatment no significant improvement is observed, the patient should be considered a non-responder and administration should be discontinued.

Use In pregnancy & Lactation: Pregnancy: There are no adequate data and well controlled studies in pregnant women. lactation : It is unknown whether flunarizine is excreted in human milk. This tablet should be used during pregnancy only if clearly needed. Caution should be exercised when this tablet is administered to a nursing woman.

Packing: Migon Tablet: Each box contains 4x14's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.